Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine
Purpose: Adenosine plays an important role in the pathogenesis of homocysteine-associated vascular complications. Methods: This study examined the effects of dipyridamole, an inhibitor for nucleoside transport, on impaired angiogenic processes caused by homocysteine and adenosine in human cardiovasc...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_1f27ac7d14d14b6f8cbf94b45e2c5ef6 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Antony Kam |e author |
700 | 1 | 0 | |a Valentina Razmovski-Naumovski |e author |
700 | 1 | 0 | |a Xian Zhou |e author |
700 | 1 | 0 | |a John Troung |e author |
700 | 1 | 0 | |a Kelvin Chan |e author |
245 | 0 | 0 | |a Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine |
260 | |b Frontiers Media S.A., |c 2015-12-01T00:00:00Z. | ||
500 | |a 10.18433/J3TG88 | ||
500 | |a 1482-1826 | ||
520 | |a Purpose: Adenosine plays an important role in the pathogenesis of homocysteine-associated vascular complications. Methods: This study examined the effects of dipyridamole, an inhibitor for nucleoside transport, on impaired angiogenic processes caused by homocysteine and adenosine in human cardiovascular endothelial cell line (EAhy926). Results: The results showed that dipyridamole restored the extracellular adenosine and intracellular S-adenosylhomocysteine concentrations disrupted by the combination of homocysteine and adenosine. Dipyridamole also ameliorated the impaired proliferation, migration and formation of capillary-like tubes of EAhy926 cells caused by the combination of homocysteine and adenosine. Mechanism analysis revealed that dipyridamole induced the phosphorylation of mitogen-activated protein kinase kinase (MEK) and extracellular signal-regulated kinases (ERK) and its effect on cell growth was attenuated by the MEK inhibitor, U0126. Conclusion: Dipyridamole protected against impaired angiogenesis caused by homocysteine and adenosine, at least in part, by activating the MEK/ERK signalling pathway, and this could be associated with its effects in suppressing intracellular S-adenosylhomocysteine accumulation. Novelty of the Work: This is the first paper showing that nucleoside transport inhibition by dipyridamole reduced impaired angiogenic process caused by homocysteine and adenosine. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page. | ||
546 | |a EN | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Pharmacy & Pharmaceutical Sciences, Vol 18, Iss 5 (2015) | |
787 | 0 | |n https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/25377 | |
787 | 0 | |n https://doaj.org/toc/1482-1826 | |
856 | 4 | 1 | |u https://doaj.org/article/1f27ac7d14d14b6f8cbf94b45e2c5ef6 |z Connect to this object online. |